Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways

Craig Ledgerwood, Sam M. Greenwood, R.R. Brett, J.A. Pratt, T. Bushell

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices. Experimental approach: The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively. Key results: CBD decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid CB1 receptor inverse agonist, LY320135 but were unaffected by the 5-HT1A receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB1 receptor antagonist, AM251, in addition to LY320135 and WAY100135. Conclusions and implications: CBD reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT1A and CB1 receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.
Original languageEnglish
Pages (from-to)286-294
Number of pages9
JournalBritish Journal of Pharmacology
Volume162
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Cannabidiol
Synaptic Transmission
Cannabinoid Receptor CB1
Receptor, Serotonin, 5-HT1A
Serotonin 5-HT1 Receptor Antagonists
Pertussis Toxin

Keywords

  • cannabidiol
  • hippocampus
  • synaptic transmission
  • 5-HT1A
  • CB1

Cite this

@article{616b38fd8ff4482c8f590da7cfabc009,
title = "Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways",
abstract = "Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices. Experimental approach: The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively. Key results: CBD decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid CB1 receptor inverse agonist, LY320135 but were unaffected by the 5-HT1A receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB1 receptor antagonist, AM251, in addition to LY320135 and WAY100135. Conclusions and implications: CBD reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT1A and CB1 receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.",
keywords = "cannabidiol, hippocampus, synaptic transmission, 5-HT1A, CB1",
author = "Craig Ledgerwood and Greenwood, {Sam M.} and R.R. Brett and J.A. Pratt and T. Bushell",
year = "2011",
month = "1",
doi = "10.1111/j.1476-5381.2010.01015.x",
language = "English",
volume = "162",
pages = "286--294",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
number = "1",

}

Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways. / Ledgerwood, Craig; Greenwood, Sam M.; Brett, R.R.; Pratt, J.A.; Bushell, T.

In: British Journal of Pharmacology, Vol. 162, No. 1, 01.2011, p. 286-294 .

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways

AU - Ledgerwood, Craig

AU - Greenwood, Sam M.

AU - Brett, R.R.

AU - Pratt, J.A.

AU - Bushell, T.

PY - 2011/1

Y1 - 2011/1

N2 - Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices. Experimental approach: The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively. Key results: CBD decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid CB1 receptor inverse agonist, LY320135 but were unaffected by the 5-HT1A receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB1 receptor antagonist, AM251, in addition to LY320135 and WAY100135. Conclusions and implications: CBD reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT1A and CB1 receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.

AB - Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices. Experimental approach: The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively. Key results: CBD decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid CB1 receptor inverse agonist, LY320135 but were unaffected by the 5-HT1A receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB1 receptor antagonist, AM251, in addition to LY320135 and WAY100135. Conclusions and implications: CBD reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT1A and CB1 receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.

KW - cannabidiol

KW - hippocampus

KW - synaptic transmission

KW - 5-HT1A

KW - CB1

U2 - 10.1111/j.1476-5381.2010.01015.x

DO - 10.1111/j.1476-5381.2010.01015.x

M3 - Article

VL - 162

SP - 286

EP - 294

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -